D-Leucine amide-CDDO-Me-HMP
D-Leucine amide-CDDO-Me-HMP is a prodrug composed of CDDO-Me (HY-13324) and ligustrazine (HY-N0264). D-Leucine amide-CDDO-Me-HMP can protect against CCl4-induced liver injury. D-Leucine amide-CDDO-Me-HMP can inhibit ROS production, alleviates mitochondrial damage and inhibits cell apoptosis. D-Leucine amide-CDDO-Me-HMP can be used for the research of liver injury.
For research use only. We do not sell to patients.
- CAS No.: 2749600-16-4
- Formula: C53H73N5O6
- Molecular Weight:876.18
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Caspase Isoforms
More
Biological Activity
Description
In Vitro
D-Leucine amide-CDDO-Me-HMP (CHL) (0.05-0.10 μM, 24 h) significantly enhances cell viability in CCl4-induced LO2 and RAW264.7 liver injury cell models[1].
D-Leucine amide-CDDO-Me-HMP (0.05-0.10 μM, 24 h) reduces ROS levels, alleviates mitochondrial damage and inhibits cell apoptosis in CCl4-induced LO2 and RAW264.7 liver injury cell models[1].
D-Leucine amide-CDDO-Me-HMP (0.10 μM, 24 h) significantly upregulates the expression of Nrf2 and HO-1 proteins in CCl4-induced LO2 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:CCl4 induced LO2 and RAW264.7 liver injury cells
-
Concentration:0.05 and 0.10 μM
-
Incubation Time:24 h
-
Result:Showed cell viability of 98.4% in LO2 cells and 92.6% in RAW264.7 cells.
-
Cell Line:CCl4 induced LO2 and RAW264.7 liver injury cells
-
Concentration:0.05 and 0.10 μM
-
Incubation Time:24 h
-
Result:Reduced the fluorescence intensity of DCF.
Reduced the fluorescence intensity of J-monomer and Increased the fluorescence intensity of J-aggregate.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 (8 weeks of age, 18–20 g, CCl4-induced liver injury)[1]
-
Dosage:15 mg/kg, 30 mg/kg
-
Administration:Intraperitoneally injection
-
Result:Reduced serum levels of ALT and AST.
Alleviated steatosis and inflammatory infiltration.
Upregulated the expression of HO-1 (4.2-fold) and NQO1 (5.5-fold) in liver tissue.
Downregulated the expression of p-p65 (5-fold) and pro-apoptotic protein BAX.
Upregulated the expression of anti-apoptotic protein Bcl-2, and inhibited excessive activation of Caspase-3.
Chemical Information
-
CAS No. 2749600-16-4
-
Molecular Weight 876.18
-
Formula C53H73N5O6
-
SMILES
[H][C@@]12CC(C)(CC[C@@]1(CC[C@]3([C@@]4(CC[C@]5(C(C)(C(OCC6=CC=C(C=C6)NC([C@@H](CC(C)C)N)=O)=C(C([C@@]5(C4=CC([C@]23[H])=O)C)OCC7=NC(C)=C(N=C7C)C)C#N)C)[H])C)C)C(OC)=O)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)